Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials

Cesne, A. le; Ouali, M.; Leahy, M.G.; Santoro, A.; Hoekstra, H.J.; Hohenberger, P.; ... ; Graaf, W.T.A. van der (2014)

Article / Letter to editor

• soft tissue sarcoma
• adjuvant chemotherapy
• predictive factors
• treatment outcome

• All authors: Cesne, A. le; Ouali, M.; Leahy, M.G.; Santoro, A.; Hoekstra, H.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Hoesel, R. van; Verweij, J.; Bonvalot, S.; Steward, W.P.; Gronchi, A.; Hogendoorn, P.C.W.; Litiere, S.; Marreaud, S.; Blay, J.Y.; Graaf, W.T.A. van der
• Date: 2014-12-31
• Journal: Annals of Oncology
• Volume: 25
• Issue: 12
• Pages: 2425 - 2432
• DOI: doi:10.1093/annonc/mdu460